According to a new study, Δ9-tetrahydrocannabinol acid (THCA) has potent neuroprotective activity which may help treat Huntington´s Disease and other neurodegenerative and neuroinflammatory diseases. “Phytocannabinoids are produced in Cannabis sativa L. in acidic form and are decarboxylated upon heating, processing, and storage”, states the abstract of the study, published by the British Journal of Pharmacology …
According to a new study, tetrahydrocannabinolic acid (THCA), a compound found in cannabis, may be useful in treating neurodegenerative and neuroinflammatory diseases. “While the biological effects of decarboxylated cannabinoids such as Δ9-tetrahydrocannabinol (Δ9-THC) have been extensively investigated, the bioactivity of Δ9-THCA is largely unknown, despite its occurrence in different Cannabis preparations”, states the study, published …
Cannabidiol (CBD), a cannabis compounds, may be useful in treating anxiety-related disorders as well a substance abuse disorders, according to a new study, “[C]annabidiol, the main non-psychotomimetic phytocannabinoid found in Cannabis sativa, reduces anxiety”, states the abstract of the study, published by the British Journal of Pharmacology and the U.S. National Institute of Health. “There is …
A new study published by the British Journal of Pharmacology has found that cannabinoids may protect against the behavioral disturbances caused by an essential tremor. “Essential tremor (ET) is a neurological disorder with unknown etiology”, states the study’s abstract. “Its symptoms include cerebellar motor disturbances, cognitive and personality changes, hearing and olfactory deficits.” For the …
Tetrahydrocannabinol (THC) can serve as a suppressor of Staphylococcal enterotoxin B-induced pulmonary inflammation, reducing the morality rate of the ailment, according to a study published in the British Journal of Pharmacology. According to researchers; “The superantigen Staphylococcal enterotoxin B (SEB) is a potent activator of Vβ8+T-cells which results in the clonal expansion of ∼30% of …
A nearly 10-year long study conducted by researchers at California Pacific Medical Center’s Research Institute, and published this month by the British Journal of Pharmacology, has found that cannabinoids can combat breast cancer progression. “The psychoactive cannabinoid Δ9 -tetrahydrocannabinol (THC) and the non-psychoactive cannabinoid cannabidiol (CBD) can both reduce cancer progression each through distinct antitumor …
A new study published in the British Journal of Pharmacology has found that cannabis may treat neurodegenerative diseases such as Alzheimer’s disease. “In an increasingly ageing population, the incidence of neurodegenerative disorders such as Alzheimer’s disease, Parkinson’s disease and Huntington’s disease are rising”, according to the study. “While the aetiologies of these disorders are different, …
A new study published by the British Journal of Pharmacology has found that not only can CBD (cannabidiol, a cannabis compound) protect breast cancer patients against neurotoxicity and pain associated with chemotherapy drugs, it can actually increase the cancer-fighting capabilities of these drugs. According to researchers; “Paclitaxel (PAC) is associated with a chemotherapy-induced neuropathic pain (CIPN) …
A new study published this week by the U.S. National Institute of Health, as well as the British Journal of Pharmacology, has found that activation of the brain’s cannabinoid receptors – something which cannabis does naturally – provides neuroprotective effects that can reverse impaired neurogenesis caused by HIV-related dementia.
A new study published in this month’s issue of the British Journal of Pharmacology has found that cannabis can stop seizures due to its “significant anticonvulsant effects”. For the study researchers used an extract made from the whole cannabis plant, and used the substance on a number of animal models – using rats and mice …
